RANKL-IN-1

RANKL-IN-1 is a selective inhibitor of receptor activator of nuclear factor-κB ligand (RANKL), with a KD value of 7.6 μM. It shows inhibitory activity and selectivity in osteoclastogenesis, with an IC50 of 0.07 μM and a selectivity index (SI) of 82.57. By directly binding to RANKL, RANKL-IN-1 blocks the activation of RANKL-induced NF-κB and MAPK pathways. This compound is applicable in research on metabolic diseases such as osteoporosis.